chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ARM SWELLED UP; BRUISES AROUND AREA PUNCTURED TURNED BLACK AND BLUE; This spontaneous report received from a parent concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced arm swelled up, and bruises around area punctured turned black and blue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm swelled up and bruises around area punctured turned black and blue was not reported. This report was non-serious. This parent/child case is linked to 20210555169.
a week after treatment started breaking out in hives and face swelling; experience on and off for last two weeks
Sore left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 (at an age of 58-year-old) as single dose for COVID-19 immunisation. The medical history of the patient included COVID-19 respiratory infection. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. Concomitant medications were not reported. On 02Apr2021 at 06:00, the patient experienced sore left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The patient underwent lab test on 20Apr2021 which included SARS-CoV-2 test (nasal swab) and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event of sore left arm was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
axillary lymphadenopathy with palpable node and pain with bringing pec towards midline
Information has been received from a nurse concerning a 48 year old male who on 12-OCT-2006 was vaccinated with Pneumovax 23 (lot # 651400/0618F) 0.5 ml, IM into left arm at 1215 hours. Concomitant therapy included LUNESTA. On 13-OCT-2006 at 1100 hours, the patient experienced his injection site was red, warm, and tender to the touch. the patient had no fever. The patient visited the physician's office with a complaint of a site reaction stating that it was very painful. The nurse informed the patient to take TYLENOL, CIPRO, BENADRYL during the day. The nurse requested a lot check. At the time of reporting, the patient had not recovered. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released by the regulatory agency. Additional information has been requested.
Patient states she received the vaccine on the 23rd of April and started to notice itching on the 25th. She then broke out in a head to toe rash
Cardiac Irregularity, Diagnosed as Atrial fibrillation in Oct 2021
Large local reaction noted in upper arm. Area size of softball/baseball. Area hard & red & warm to touch. Left arm.
Redness, itching, pain & swelling at site of immuniz. within 24h of injection (R deltoid).  Dx-local hypersensitivity reaction.  Tx-local ice, BENADRYL, reassurance.
Within two hours of getting my second vaccine shot, my arm became extremely red and swollen.  In the following days my arm remained swollen and hot to the touch.  Since that time I have experienced extreme pulling from the base of my neck to my shoulder and the upper portion of my shoulder.  I have not been able to get much relief with a consistent tension and pain  which has restricted my range of motion.
I went to the clinic around 10 AM. I went with the intention of receiving my SECOND booster shot, as advertised on the pamphlets and papers. I also wrote on my paperwork and verbally told the individuals mult. Times what I wanted to receive. I also received my Flu vaccine, I am unsure of the exact lot number and type of four shot, but I assume it is the most popular for this season. The shots went well and I was on my way. Yesterday, 10/13/22 I received a call and voicemail. When I called the number back the person, told me that I had ?accidentally? received the WRONG vaccine. He told me that I received the vaccine that I already have, my first booster. He told me I now have essentially 2 of the same boosters in my body, and I will not be able to get the new booster until December. He then asked for the lot number on my vaccine card, there was none. He seemed concerned that there was no lot number on my card, and told me to ?write it in.? I wrote the number and letter sequence in, and in addition he told me to write his cell phone number at the top of my vaccine card, ?just in case anyone has questions  when administering future shots.? I then asked him if I would be ok with these 2 shots in my system and he said yes. I asked how he knew, and said that from a ?health standpoint? I should be fine. I faced no side effects out of the ordinary, but am now slightly worried for not only my health, but for the other individuals effects by this complete lack of attention, and malpractice.
Patient  had just received the DTAP (GSK 7H399).  Then, she received the Varicella.  She immediately began to hold her breath.for several seconds.  She lost consciousness lasting 2-3 seconds.  She aroused spontaneously and began to cry.  She was alert.  There was no noted swelling or redness at the site of injection or anywhere on the body.  Her breathing was normal with no audible congestion.  Her pulse ox on room air was 98%.
This spontaneous report was received from a 66 year old female patient, reporting on herself. The patient's concurrent conditions included high blood pressure, unspecified neuropathy and allergy "to cholesterol medicine". Concomitant therapies included acyclovir and other unspecified medications. In September 2016, the patient was vaccinated with ZOSTAVAX (strength, dose, route, lot number and expiration date were not reported) for prevention of shingles.      Approximately in January 2017 (reported as "about two weeks ago"), the patient experienced singles. On an unknown date, she visited an unspecified emergency room for a different unspecified reason and was diagnosed with shingles. The patient reported that she received no treatment for the shingles, because she was on acyclovir therapy on a regular basis and was also "beyond the scab stage" when she was seen in the emergency room. Therefore, she "hung out at home and beared it". Additionally, the patient explained "it still burns and stings like it want to break out". No labs diagnostics were performed. No product quality complain was reported. The causal relationship between the event and the suspect therapy was not provided. Additional information has been requested.
No adverse effect; patient received a subcutaneous dose of M-MR II and Varivax on 04-NOV-2008; This spontaneous report was received from a Licensed Practical Nurse referred to a patient of unknown age and gender. Information regarding medical history and concurrent conditions were not reported. On 04-NOV-2008 the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # 0043X, expiry date 19-DEC-2009, via subcutaneous route for prophylaxis (dose was not reported). On the same day, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # 1216X and expiry date 27-AUG-2010 via subcutaneous route for prophylaxis (dose was not reported) (Inappropriate schedule of product administration). Concomitant therapies included influenza virus 3v reassortant vaccine live intranasal (cold adapted ann arbor master strain)(FLUMIST (INFLUENZA VIRUS 3V REASSORTANT VACCINE LIVE INTRANASAL (COLD ADAPTED ANN ARBOR MASTER STRAIN))) and sterile diluent (STERILE DILUENT). No adverse effects were reported. Product quality complaint was not involved.
Pain in arm pit gland; Flu like symptoms; This non-serious case was reported by a consumer and described the occurrence of axillary pain in a 58-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included TETANUS VACCINE for prophylaxis.   On 02-MAY-2023, the patient received Shingles vaccine and TETANUS VACCINE. On 03-MAY-2023, 1 days after receiving Shingles vaccine, the patient experienced axillary pain (Verbatim: Pain in arm pit gland) and influenza-like symptoms (Verbatim: Flu like symptoms). The outcome of the axillary pain was not resolved and the outcome of the influenza-like symptoms was resolved.   It was unknown if the reporter considered the axillary pain and influenza-like symptoms to be related to Shingles vaccine.     It was unknown if the company considered the axillary pain and influenza-like symptoms to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-MAY-2023 The patient received Shingles vaccine and experienced the pain in arm pit of same arm as vaccine persist and flu like symptoms. The Flu-like symptoms was subsided and the armpit pain was persisted. It was unknown if the reporter considered the axillary pain and influenza-like symptoms to be related to tetanus vaccine. The reporter was requested for consent to follow up.
pt states that she woke up next day w/ severe epigastric pain, nausea, vomiting, loss of appetite, dark urine, pale stools.  pt was very sick from 3/5 to 3/13.  She had an appt w/ PCP on 3/19/21 for her annual exam.  Labs showed her liver enzymes were elevated.  Her labs were all high on this date but normal one year ago.  Dr. told her the vaccine caused her to have vaccine induced hepatitis.  Pt to FU w/ PCP on 4/22/21.
Patient fainted immediately after standing up from getting vaccine, fell back and bumped head on wall. Patient was given cold pack and gatorade and closely observed for 15 more minutes upon which time mom felt safe to take home.
On 3-15-21 patient received 1st dose Pfizer vaccine on L deltoid, states that 2 days after the jab she developed a pruriginous rash on ventral aspect of L forearm above wrist area. Rash faded away on its own. Denied SOB, wheezing, cough, facial swelling. denied any rashes on other areas of her body. she did not disclose that rash to us at the clinic. On 04/05/21 she came to the clinic for 2nd jab, on screening and immunization documentation she mark no on "like to speak with health care provider" but prior to HS providing 2nd jab she brought to her attention the previous symptoms. I intervene and discuss with the patient and asked the nature of the previous symptoms. Due to a miscommunication and misunderstanding, on my part, I thought that her rash was initially on site of injection and that it spread distally, discuss with her Covid arm for about 10-15 minutes with patient as I thought initially that it was a COVID arm and proceed to allow 2nd jab and order to keep her in observation for 30'. 2nd jab administered on R arm this time. About 3 minutes after jab, she developed  three lesions on forearm, 2 bumps approximately .2 cm diameter, with mild hyperemia on dorsal aspect of proximal forearm which states were itching. Stated one hyperemic non raised lesion on proximal ventral forearm (that latest lesion was not visualized by me). I extended the observation period and at 45' the lesions started to fade away and the "bumps" got smaller. I did a full evaluation of the patient and there was no other skin lesions on rest of her body. she was breathing normally, no wheezings, no laryngeal stridor, no facial/neck/lips/tongue swelling, no complaints of tingling on lips or tongue. She was not on distress. No treatment provided to patient. Patient was discharge home with specific instructions to call 911, go to neares ER, or call the Duty HS if at any point she develops any new symptoms, breathing problems. Around 6:15 i call patient and told me she was doing good, no new skin lesion, no laboured breathing, wheezing, swelling, problems with swallow and that the lesions were gone. Today 4/6/21 I call patient to come to the clinic for re-assessment and there was no skin rashes, no swelling, her exam was completely normal. she complained of tender arm and that previous night she had some mild headache, took tylenol and better. There was no redness around injection site. Patient was discharged with same recommendations provided previously, to call 911, go to nearest ER, or call Duty HS if any new skin lesions, SOB, wheezing, difficulty swallowing or talking. Just spoke with patient via phone today at 4:25 PM and states she is doing well, no rash, no SOB, completely asymptomatic. I understand the magnitude of these events and I have to say the the misunderstanding was all on me and I take responsibility. Here in our clinic we have immunized over 600 patients and no major issues prior to this. I am available to discuss at any time. Thanks,
Blood clots in lungs. May / probably formed in limbs and went unnoticed until severe pain in lower left bottom back.  Also DVT in left leg.
Incredibly sharp pain in my lower right back - came on  gradually over about 30 minutes until I couldn?t stand. Laid down on bed on my side to find relief and couldnt.  Worst pain I?d experienced since shattering my elbow. Took 4 Advil and heating pad and eventually pain reduced over the next half hour.
Next day post vax, the pt broke out in rash, vomited once and had fatigue. Also, complained of itching and has been taking Benadryl.
Tested positive for COVID19; shortness of breath; headache; loss of 20 pounds; really high fever; Felt very sick; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), PYREXIA (really high fever) and MALAISE (Felt very sick). On 21-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID19). On 28-Jan-2021, PYREXIA (really high fever) had resolved. At the time of the report, DYSPNOEA (shortness of breath), HEADACHE (headache), WEIGHT DECREASED (loss of 20 pounds), MALAISE (Felt very sick) and SARS-COV-2 TEST POSITIVE (Tested positive for COVID19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included Steroids, acetaminophen, Inhaler and other OTC medicines
The lymph node above my left clavicle bone got enlarged/ swelling went down a few days later, but now 6 months later, you can still feel the enlarged lymph node.; The lymph node above my left clavicle bone got enlarged and hurt when touched a few days after getting the second dose of the vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Feb2021 18:00 (Lot number: EN6201) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "obesity" (unspecified if ongoing); "general anxiety disorder" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; DULOXETINE; PANTOPRAZOLE; VITAMIN D NOS. Past drug history included: Erythromycin, reaction(s): "Drug allergy". Vaccination history included: Bnt162b2 (dose number=1, brand=Pfizer, lot number=EL9262, administration time=06:00 PM, vaccine location=Left arm), administration date: 26Jan2021, when the patient was 41 years old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 25Feb2021, outcome "not recovered", described as "The lymph node above my left clavicle bone got enlarged/ swelling went down a few days later, but now 6 months later, you can still feel the enlarged lymph node."; LYMPH NODE PAIN (non-serious) with onset 25Feb2021, outcome "not recovered", described as "The lymph node above my left clavicle bone got enlarged and hurt when touched a few days after getting the second dose of the vaccine". The events "the lymph node above my left clavicle bone got enlarged/ swelling went down a few days later, but now 6 months later, you can still feel the enlarged lymph node." and "the lymph node above my left clavicle bone got enlarged and hurt when touched a few days after getting the second dose of the vaccine" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain.  Additional information: Patient had a mammogram in June to rule out anything and fortunately everything was normal. But it was still worrisome since it was suppose to go away, reported it to her doctor 2 months after the last dose of her vaccine as suggested if it was still there. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Urticaria developed 24 hours after immunizations over entire body - prescribed diphenhydramine. No respiratory sx.
p/vax pt exp h/a; nausea; quarters 24hr; darvocet; phenergan
Swelling of the face and throat, difficulty talking, red and itchy eyes, fast heartbeat.
Information has been received from a certified medical assistant referring to unspecified numbers of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates these patients were vaccinated with improperly stored RECOMBIVAX HBA (lot # L009155, expiration date: 29-OCT-2016, strength, dose and route unknown) (incorrect product storage). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
There was a temperature excursion that occurred on 26-JAN-2023, the temperature went up to 8.4 C; No adverse event; Patients had been administered doses of the monovalent vaccine post excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients had been administered doses of the monovalent vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (There was a temperature excursion that occurred on 26-JAN-2023, the temperature went up to 8.4 C) and NO ADVERSE EVENT (No adverse event) in a 55-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for an unknown indication.    On 27-Jan-2023 at 6:55 PM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 27-Jan-2023 at 4:55 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients had been administered doses of the monovalent vaccine post excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was a temperature excursion that occurred on 26-JAN-2023, the temperature went up to 8.4 C) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients had been administered doses of the monovalent vaccine post excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (There was a temperature excursion that occurred on 26-JAN-2023, the temperature went up to 8.4 C) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patients had been administered doses of the monovalent vaccine post excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (There was a temperature excursion that occurred on 26-JAN-2023, the temperature went up to 8.4 C).    Patient's race was reported as black. Dosage text for suspect product was reported as unknown.  It was reported that the monovalent vial which was stored in refrigerator went temperature excursion on 26-Jan-2023. The refrigerator door was left open for 5 minutes and the temperature went up to 8.4C. The doses had been used on patients from start of the excursion till 17-Feb-2023. No adverse event was reported by patients.  Treatment medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-716594 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-Mar-2023: Patient details, vaccine details and narrative part updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716594: US-MODERNATX, INC.-MOD-2023-717419:same reporter
General fatigue about 24 hours after vaccination. Went to bed and felt fine the next day after sleeping 10 hours. While not a major reaction to the vaccine, I am reporting this minor reaction nevertheless for statistical purposes. Thank you.
The baby received vaccines about 10:30 am today. Around 3pm, the baby became fussy with a sore left leg and not feeding as well. No fever or vomiting.
I didn't have any symptoms when I tested positive.  But Monday night I began having a sore throat and headache.  I emailed doctor and she advised to treat with OTC pain reliever and throat lozenges.  On Tuesday I had the sore throat and my voice was hoarse.  In the middle of the night I was freezing and chills and had a fever.  I took fever reducing medication.  I didn't have fever and was no longer cold but I have very bad body aches.  I have no energy.
Patient started making a funny face and contorting his mouth.  He said his tongue was swelling. We kept an eye on him for about 20 minutes, he wasnt wanting to eat his lunch.  His face was also flushed which can be an indicator that he doesn't have enough prednisone on board.  We gave him an additional dose of his morning prednisone dose, 7.5 mg.  The swelling subsided in about 30 minutes, he ate and said he felt much better.  We will double his evening dose and contact his endocrine doc for more instructions.
Nauseous starting 20 hours after vaccination.  Vertigo starting 27 hours after vaccination.
Son came into Health Dept this morning to report that his father began throwing up and having diarrhea Saturday morning(05/15/2021) which progressed through the day. States did not want to go to the Hospital but wanted to wait to see his MD at the Dialysis center on Monday (05/17/2021).   On Sunday(05/16/2021) nausea and vomiting  and diarrhea was worse and now with cough noted. States was washing his hands and fainted, EMS was called and he died that morning.